| Faculty (Department Wise)+ |
|---|
| ----------------------------- |
| Chemical Sciences > |
| Pharmaceutical Analysis > |
| Biological Sciences > |
| Pharmaceutics > |
| Pharmaceutical Management > |
| Medical Devics > |
| Natural Products > |
| Regulatory Affairs > |
| Pharmacoinformatics > |
| ----------------------------- |
| Young Scientists |
| Guest Faculty |
| ----------------------------- |
| Staff + |
| ----------------------------- |
| Technical Staff |
| Administrative Staff |
Dr. Jitender Madan obtained his M.Pharmacy from Dr. Harisingh Gaur University, Saugar and Ph.D (Pharmaceutical Sciences) from Bundelkhand University, Jhansi. He also worked as Postdoctoral Fellow in Georgia State University, Atlanta, GA, USA in Cancer Nanobiology. Currently, Dr. Madan is associated with Department of Pharmaceutics, NIPER, Hyderabad and continuing academic research in the area of topical drug delivery systems, vaccine delivery, and cancer nanobiology.
Dr. Saurabh Srivastava earned his Ph.D. in Pharmaceutics from “Panjab University, Chandigarh” and pursued his Masters in Pharmaceutical Sciences from “Birla Institute of Technology and Science (BITS), Pilani, Rajasthan. He carries more than 17+ years of profound industrial and research experience working with several Pharmaceutical R&Ds, including IPCA labs, Mumbai, Wockhardt research centre, Aurangabad and His latest stint was with Dr. Reddy’s Laboratories, Hyderabad, as Tech Lead for development and commercialization of various Differentiated, NDA and ANDA based products for different regulated markets. Subsequently, he joined as an Associate Professor in the Department of Pharmaceutics, NIPER-Hyderabad. Presently he is acting as a Member (Board of Governors; NIPER-Hyderabad), Member (Board of Directors; AVISHKARAN-BIRAC-BioNEST of NIPER Hyderabad) and Head, Department of Regulatory Affairs (Add’l Charge) at NIPER Hyderabad. His Research Laboratory named Pharmaceutical Innovation and Translational Research Lab (PITRL) is predominantly working on the development and optimization of Industrially viable, feasible and scalable Differentiated formulations; (505(b)2, through the utilization of Micro/Nanostructured Targeted drug deliveries along with Novel platform technologies. His major therapeutic area of research is Diabetic Complications, Neurodegenerative disorders, Dermal diseases, Glioblastoma, Melanoma, Prostate, Breast Cancer and Oral Cancer. He has mentored 40+ Masters Research scholars, and 11 PhD Research scholars are pursuing their Doctoral research, whereas, 04 PhD Scholars have already submitted their PhD under his supervision. He and his research team are actively involved in the execution of several Extra Mural Research (EMR) Projects and Industrial research projects (~1.5 CR.) to establish novel differentiated products. He has been awarded several appreciation and “Special Recognition Awards” from Dr. Reddy’s laboratories for his outstanding contribution to research and development along with the International Travel grant from CSIR, New Delhi. He was further elected as a Fellow of the Prestigious “Telangana Academy of Sciences” (TAS) in May 2024 and Fellow of “Education Research & Development Association” (ERDA) in November 2024. He had been instrumental in 02 “Commercial Products”, 17+ “International and National Patents”, 04 Edited books, 50+ Book chapters along with 200+ Publications in Journals of International repute with h-Index of 31 and 4000+ citations further to his credit.
Full Profile
His area of interests are "Targeted drug delivery system; Ligand anchored drug targeting; Nanotechnology; Bioavailability improvement; Liposomal drug delivery system; Sustain release dosage form. He is working on targeted drug delivery system for various life-threatening disease, i.e., cancer, visceral leishmaniasis, diabetes, etc."
Full Profile
His area of interests are "Differentiated complex pharmaceutical product development of Ophthalmic, inhalation and Injectables. Formulation development of poorly water-soluble drugs using novel technologies for enhancement of efficacy. Transform of numerous Micro-, Nano-technologies based formulation including Microfluidics, bead milling techniques, Multifunctional Targeted Drug Delivery systems, Polymeric micelles, Liposomes, Nanoparticles, Dendrimers, carbon nanotubes, Quantum dots, Drug-polymer conjugates. Major Areas of Research - Ocular delivery, Onco-Target Products, Topical drug delivery, Micro-/Nanotechnologies for Bioactives Delivery and Targeting."
Full Profile